Ozempic at 0.5 mg can produce weight loss, but for most people it’s a moderate amount. A real-world study found that a dose equivalent to 0.5 mg weekly led to about 5.7% body weight loss (roughly 13 pounds for someone starting at 230) after a full year of treatment. That’s meaningful, but it’s well below what higher doses of semaglutide deliver in clinical trials, where patients on 1 mg or 2 mg doses commonly lose 10% to 15% of their body weight.
Whether 0.5 mg is “enough” depends on your goals, how your body responds, and what you’re using the medication for. Here’s what the data actually shows.
What to Expect at the 0.5 mg Dose
The 0.5 mg dose is technically a maintenance dose for blood sugar control in type 2 diabetes, not a weight loss dose. Ozempic’s FDA-approved dosing schedule starts at 0.25 mg for the first four weeks (to let your body adjust), then moves to 0.5 mg. If blood sugar targets aren’t met after at least four more weeks, the dose can increase to 1 mg weekly. For weight loss specifically, the sister drug Wegovy uses semaglutide at doses up to 2.4 mg, more than four times the 0.5 mg level.
A retrospective study of 93 adults without diabetes tracked outcomes for one year on a dose considered equivalent to 0.5 mg Ozempic weekly. The average weight loss among those who completed the study was 5.9 kg (about 13 pounds), or 5.7% of starting body weight. BMI dropped by an average of 2 points, and waist circumference shrank by about 5.5 cm (just over 2 inches). These are real, measurable changes, but the spread was wide: some people lost as much as 17% of their body weight, while others actually gained a small amount.
Nearly half the participants (48%) lost less than 5% of their body weight after a full year. Only 4% hit the 15% loss threshold that higher-dose semaglutide trials regularly achieve. So while 0.5 mg works for some people, the odds of dramatic weight loss at this dose are low.
Why Results Vary So Much
Semaglutide works by mimicking a gut hormone that slows digestion, reduces appetite, and signals fullness to the brain. At lower doses, these effects are simply less pronounced. Some people are highly sensitive to the drug and experience strong appetite suppression even at 0.5 mg, while others barely notice a change in hunger until they reach a higher dose.
Starting weight, diet, physical activity, metabolic health, and whether you have type 2 diabetes all influence outcomes. People with diabetes sometimes lose less weight on semaglutide than those without it, partly because the medication also lowers blood sugar in ways that can work against fat loss. Your individual biology matters more than any average from a study, which is why the range in that real-world data stretched from gaining 3% to losing 17% on the same dose.
Side Effects at 0.5 mg
One reason some people prefer to stay at 0.5 mg is that side effects are noticeably milder than at higher doses. In FDA clinical trials, about 33% of patients on 0.5 mg reported gastrointestinal side effects, compared to 36% on 1 mg and just 15% on placebo. The most common issues at 0.5 mg were nausea (16% of patients), diarrhea (8.5%), abdominal pain (7.3%), vomiting (5%), and constipation (5%).
Severe gastrointestinal reactions were rare at 0.5 mg, occurring in only 0.4% of patients. About 3.1% of people on this dose stopped treatment because of gut-related side effects. These numbers are lower than the 1 mg dose across the board, which is a genuine advantage for people who are sensitive to the medication. If you’re tolerating 0.5 mg well but struggling at higher doses, staying put is a reasonable trade-off, just with the understanding that weight loss will likely be more modest.
When Moving to a Higher Dose Makes Sense
The FDA labeling is straightforward: if you need more benefit after at least four weeks on 0.5 mg, the dose can be increased to 1 mg weekly. In practice, many prescribers keep patients at 0.5 mg for eight to twelve weeks before deciding, since weight loss on semaglutide tends to build gradually over months rather than appearing all at once.
If you’ve been on 0.5 mg for three months or more and your appetite suppression has faded, your weight loss has plateaued, or you haven’t lost a clinically significant amount (generally defined as 5% of starting weight), those are the typical signals that a dose increase could help. The jump from 0.5 mg to 1 mg often restarts the appetite-suppressing effect and leads to additional weight loss, though it also brings a higher chance of nausea and other gut symptoms during the adjustment period.
Making the Most of 0.5 mg
If you want to stay at 0.5 mg, whether by choice or because side effects limit you, the medication still gives you a tool to work with. The appetite reduction, even if subtle, can make it easier to eat smaller portions and resist cravings. Pairing the medication with a high-protein diet helps preserve muscle mass during weight loss and tends to amplify the fullness signal. Regular physical activity, even walking, improves the metabolic benefits beyond what the drug does alone.
Some people achieve results at 0.5 mg that rival what others get at higher doses, simply because they use the reduced appetite as a window to build better habits. The medication doesn’t do the work for you at any dose. At 0.5 mg, it just gives you a smaller push, which for some people is exactly enough.